Skip to main content
. Author manuscript; available in PMC: 2023 Oct 23.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2022 Feb 22;93(4):386–394. doi: 10.1136/jnnp-2021-326962

Table 1: Patient demographic, surgical, and symptom information.

Relevant information provided on a case-by-case basis. Patient #2 and #3 participated for both L (left) and R (right) STN surgical sessions while the remaining participated for one session. Dx (disease); LEDD (levodopa equivalent daily dose (mg)); UPDRS (Unified Parkinson’s Disease Rating Scale).

Case # Patient # Target
(R/L STN)
Handedness Sex Disease
duration
(years)
Age at
time of
study
PRE-
LEDD
PRE ON
UPDRS
PRE OFF
UPDRS
1 1 R Right F 10 63 2692.5 20 47
2 2 R Right F 17 63 1128.75 11 43
3 2 L Right F 17 63 1128.75 11 43
4 3 L Left F 10 59 1143.75 19 42
5 3 R Left F 10 59 1143.75 19 42
6 4 R Right M 8 77 505 47 67
7 5 R Right M 12 67 1496.5 58 57
8 6 R Right M 9 70 1515 32 53
9 7 L Right M 8 54 1300 33 49
10 8 L Right F 8 66 660 16 30
11 9 L Right F 13 61 1755 7 33

R – right

L – left

LEDD – levodopa equivalent daily dose (mg)

UPDRS – Unified Parkinson’s disease rating scale